The cost of screening for diabetes and intermediate hyperglycaemia.
Stephen
S
Colagiuri
D003362:Cost-Benefit Analysis; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000175:diagnosis* / Q000191:economics* / Q000453:epidemiology; D018149:Glucose Intolerance / Q000150:complications / Q000175:diagnosis / Q000191:economics / Q000453:epidemiology; D005951:Glucose Tolerance Test / Q000191:economics / Q000706:statistics & numerical data; D017048:Health Care Costs / Q000706:statistics & numerical data / Q000639:trends; D006801:Humans; D006943:Hyperglycemia / Q000150:complications / Q000175:diagnosis* / Q000191:economics* / Q000453:epidemiology; D008403:Mass Screening / Q000191:economics*; D015995:Prevalence